Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus

Stacy Cooper, Robert J. Arceci, Christopher Gamper, David T. Teachey, Eric S. Schafer

Research output: Contribution to journalArticle

Abstract

Sinus histiocytosis with massive lymphadenopathy (SHML), or Rosai-Dorfman disease (RDD), is a non-neoplastic, lymphoproliferative disorder that usually resolves spontaneously or with minimal conventional chemotherapy. Rarely, SHML can be associated with autoimmune findings. Such cases are often treatment resistant and have high rates of morbidity and mortality. We present a case of a patient with long-standing autoimmunity in the context of SHML, dependent on standard-treatment until he was transitioned to novel monotherapy with sirolimus. Sirolimus treatment resulted in a complete remission, now sustained after discontinuation of all treatments for over 23 months, with no observable long-term sequelae.

Original languageEnglish (US)
Pages (from-to)358-360
Number of pages3
JournalPediatric Blood and Cancer
Volume63
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Sinus Histiocytosis
Sirolimus
Lymphoproliferative Disorders
Therapeutics
Autoimmunity
Morbidity
Drug Therapy
Mortality

Keywords

  • autoimmune cytopenia
  • Rosai-Dorfman disease
  • sirolimus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus. / Cooper, Stacy; Arceci, Robert J.; Gamper, Christopher; Teachey, David T.; Schafer, Eric S.

In: Pediatric Blood and Cancer, Vol. 63, No. 2, 01.02.2016, p. 358-360.

Research output: Contribution to journalArticle

@article{8d816f2a96cc459bb1edc5dd171df7e3,
title = "Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus",
abstract = "Sinus histiocytosis with massive lymphadenopathy (SHML), or Rosai-Dorfman disease (RDD), is a non-neoplastic, lymphoproliferative disorder that usually resolves spontaneously or with minimal conventional chemotherapy. Rarely, SHML can be associated with autoimmune findings. Such cases are often treatment resistant and have high rates of morbidity and mortality. We present a case of a patient with long-standing autoimmunity in the context of SHML, dependent on standard-treatment until he was transitioned to novel monotherapy with sirolimus. Sirolimus treatment resulted in a complete remission, now sustained after discontinuation of all treatments for over 23 months, with no observable long-term sequelae.",
keywords = "autoimmune cytopenia, Rosai-Dorfman disease, sirolimus",
author = "Stacy Cooper and Arceci, {Robert J.} and Christopher Gamper and Teachey, {David T.} and Schafer, {Eric S.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/pbc.25770",
language = "English (US)",
volume = "63",
pages = "358--360",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus

AU - Cooper, Stacy

AU - Arceci, Robert J.

AU - Gamper, Christopher

AU - Teachey, David T.

AU - Schafer, Eric S.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Sinus histiocytosis with massive lymphadenopathy (SHML), or Rosai-Dorfman disease (RDD), is a non-neoplastic, lymphoproliferative disorder that usually resolves spontaneously or with minimal conventional chemotherapy. Rarely, SHML can be associated with autoimmune findings. Such cases are often treatment resistant and have high rates of morbidity and mortality. We present a case of a patient with long-standing autoimmunity in the context of SHML, dependent on standard-treatment until he was transitioned to novel monotherapy with sirolimus. Sirolimus treatment resulted in a complete remission, now sustained after discontinuation of all treatments for over 23 months, with no observable long-term sequelae.

AB - Sinus histiocytosis with massive lymphadenopathy (SHML), or Rosai-Dorfman disease (RDD), is a non-neoplastic, lymphoproliferative disorder that usually resolves spontaneously or with minimal conventional chemotherapy. Rarely, SHML can be associated with autoimmune findings. Such cases are often treatment resistant and have high rates of morbidity and mortality. We present a case of a patient with long-standing autoimmunity in the context of SHML, dependent on standard-treatment until he was transitioned to novel monotherapy with sirolimus. Sirolimus treatment resulted in a complete remission, now sustained after discontinuation of all treatments for over 23 months, with no observable long-term sequelae.

KW - autoimmune cytopenia

KW - Rosai-Dorfman disease

KW - sirolimus

UR - http://www.scopus.com/inward/record.url?scp=84973483412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973483412&partnerID=8YFLogxK

U2 - 10.1002/pbc.25770

DO - 10.1002/pbc.25770

M3 - Article

C2 - 26452062

AN - SCOPUS:84944096756

VL - 63

SP - 358

EP - 360

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 2

ER -